Jane Street Group LLC Acquires Shares of 57,159 Vivani Medical, Inc. (NASDAQ:VANI)

Jane Street Group LLC bought a new stake in shares of Vivani Medical, Inc. (NASDAQ:VANI) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 57,159 shares of the company’s stock, valued at approximately $66,000. Jane Street Group LLC owned 0.10% of Vivani Medical as of its most recent SEC filing.

Separately, Northern Trust Corp raised its holdings in shares of Vivani Medical by 19.1% during the fourth quarter. Northern Trust Corp now owns 71,915 shares of the company’s stock worth $83,000 after acquiring an additional 11,540 shares in the last quarter. Institutional investors and hedge funds own 6.78% of the company’s stock.

Vivani Medical Stock Performance

Shares of NASDAQ VANI opened at $1.15 on Monday. The business has a 50 day simple moving average of $1.07 and a 200 day simple moving average of $1.15. Vivani Medical, Inc. has a 52 week low of $0.91 and a 52 week high of $2.09. The stock has a market cap of $68.13 million, a price-to-earnings ratio of -2.56 and a beta of 2.93.

Vivani Medical (NASDAQ:VANI) last posted its earnings results on Tuesday, May 13th. The company reported ($0.11) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.01). On average, analysts predict that Vivani Medical, Inc. will post -0.41 EPS for the current year.

Analysts Set New Price Targets

Separately, HC Wainwright restated a “buy” rating and issued a $4.00 target price on shares of Vivani Medical in a research note on Monday, May 19th.

Insider Buying and Selling

In related news, Director Gregg Williams bought 34,000 shares of the business’s stock in a transaction on Friday, April 4th. The shares were bought at an average cost of $0.99 per share, for a total transaction of $33,660.00. Following the completion of the acquisition, the director now directly owns 4,754,800 shares in the company, valued at approximately $4,707,252. This represents a 0.72% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Over the last three months, insiders acquired 120,662 shares of company stock worth $120,526. Corporate insiders own 46.40% of the company’s stock.

Vivani Medical Profile

Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.